SCHEMBL7324975

SCHEMBL7324975

O=Cc1ccc(OCCC2CNCCO2)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 2/20 0.46
ALDH1A1 P00352 3/20 0.42
KDM4E B2RXH2 1/20 0.42
SLC6A4 P31645 10/20 0.40
SLC6A2 P23975 9/20 0.40
SLC6A3 Q01959 6/20 0.40
HTR2A P28223 4/20 0.40
HTR2B P41595 2/20 0.40
LMNA P02545 1/20 0.40
MAPT P10636 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
ADRB2 P07550 1/20 0.40
HTR1A P08908 1/20 0.40
ADRA1A P35348 1/20 0.40
ADRA2C P18825 1/20 0.40
MKNK1 Q9BUB5 1/20 0.37
ITGB3 P05106 1/20 0.36
ITGA2B P08514 1/20 0.36
HRH1 P35367 1/20 0.36
OPRD1 P41143 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7216614 0.83 SLC6A4 (0.44) HPGDSLC6A4SLC6A2SLC6A3HTR2A
SCHEMBL2761385 0.82 SLC6A4 (0.43) HPGDSLC6A4SLC6A2SLC6A3HTR2A
SCHEMBL5116224 0.82 SLC6A4 (0.43) HPGDSLC6A4SLC6A2SLC6A3HTR2A
SCHEMBL9385927 0.82 MEN1 (0.48) ALDH1A1
SCHEMBL7349980 0.80 SLC6A4 (0.41) HPGDSLC6A4SLC6A2SLC6A3HTR2A
SCHEMBL8104626 0.80 ALDH1A1 (0.49) HPGDALDH1A1KDM4ELMNAMAPT
SCHEMBL6941071 0.80 SLC6A4 (0.46) HPGDSLC6A4SLC6A2SLC6A3HTR2A
SCHEMBL8338592 0.78 HPGD (0.65) HPGDALDH1A1KDM4ELMNAMAPT
SCHEMBL6834244 0.76 SLC6A2 (0.39) ALDH1A1KDM4ESLC6A4SLC6A2SLC6A3
SCHEMBL9380023 0.76 TDP1 (0.46) ALDH1A1SLC6A4SLC6A2SLC6A3HTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5990135-A FOR TREATING A RETROVIRAL INFECTION SUCH AS HIV INFECTION; FOR EXAMPLE 5S-N-((2-PYRIDINYL)METHOXYCARBONYL)VALINYLAMINO-2-((N-3 -PYRIDINYL)METHOXYCARBONYL)AMINO-4S-HYDROXY-1,6-DIPHENYL-2-AZAHEXANE AND OTHER COMPOUNDS OF GIVEN FORMULA ABBOTT LABORATORIES (US) 1999-11-23 US disclosed
US-5631376-A PEPTIDE DERIVATIVES FOR TREATMENT OF AIDS ABBOTT LABORATORIES (US) 1997-05-20 US disclosed
US-5621109-A OXAZOLE/THIAZOLE DERIVATIVES OF HYDROXYMETHYL HYDRAZONES; SIDE EFFECT REDUCTION ABBOTT LABORATORIES (US) 1997-04-15 US disclosed
EP-0683772-A1 RETROVIRAL PROTEASE INHIBITING COMPOUNDS ABBOTT LABORATORIES (US) 1995-11-29 EP disclosed
US-5461067-A For HIV infections ABBOTT LABORATORIES (US) 1995-10-24 US disclosed
EP-0683772-A4 RETROVIRAL PROTEASE INHIBITING COMPOUNDS. ABBOTT LAB (US) 1995-09-27 EP disclosed
WO-1994019332-A1 RETROVIRAL PROTEASE INHIBITING COMPOUNDS ABBOTT LABORATORIES (US) 1994-09-01 WO disclosed